MRI evaluation of the endolymphatic space in otosclerosis and correlation with clinical findings.


Journal

Diagnostic and interventional imaging
ISSN: 2211-5684
Titre abrégé: Diagn Interv Imaging
Pays: France
ID NLM: 101568499

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 17 02 2020
revised: 16 03 2020
accepted: 19 03 2020
pubmed: 8 4 2020
medline: 13 7 2021
entrez: 8 4 2020
Statut: ppublish

Résumé

The purpose of this study was to investigate the clinical features of ears with otosclerosis and their correlation with endolymphatic hydrops and blood-labyrinth barrier (BLB) impairment on 3T magnetic resonance imaging (MRI). This was a single-center retrospective imaging study. Thirty-nine ears from 29 patients (17 men, 12 women; mean age 52±12 [SD] years; range 27-74 years) with non-operated otosclerosis were included. All patients underwent three-dimensional fluid attenuated inversion recovery (FLAIR) MRI sequences performed 4hours after the intravenous administration of a single dose of gadolinium-based contrast material. MRI examinations were analyzed by two radiologists for the presence of saccular hydrops (SH) and BLB impairment. Results of MRI examinations were compared with clinical findings, hearing levels and extent of otosclerotic lesions based on high-resolution computed tomography findings. BLB impairment was evaluated using the signal intensity ratio, ratio of intensities between the basal turn of the cochlea and the medulla. SH was observed in 1/39 (3%) otosclerotic ears and BLB impairment in 8/39 (21%) while 8/29 patients with otosclerosis (28%) had vertigo. No significant associations were found between SH or BLB impairment on MRI, and the presence of vertigo or the degree of sensorineural hearing loss. Clinical manifestations of otosclerosis (sensorineural hearing loss and rotatory vertigo) were not significantly associated with MRI findings such as BLB impairment and endolymphatic hydrops. SH was only observed in one patient with obstruction of the vestibular aqueduct by an otosclerotic focus.

Identifiants

pubmed: 32253140
pii: S2211-5684(20)30086-3
doi: 10.1016/j.diii.2020.03.009
pii:
doi:

Substances chimiques

Contrast Media 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

537-545

Informations de copyright

Copyright © 2020 Société française de radiologie. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

J Laine (J)

Department of Neuroradiology, Lariboisière University Hospital, Assistance Publique-Hopitaux de Paris, 75010 Paris, France.

C Hautefort (C)

Department of Head & Neck Surgery, Lariboisière University Hospital, Assistance Publique-Hopitaux de Paris, 75010 Paris, France.

A Attye (A)

Department of Neuroradiology and MRI, Grenoble Alpes University Hospital, 38000 Grenoble, France.

J-P Guichard (JP)

Department of Neuroradiology, Lariboisière University Hospital, Assistance Publique-Hopitaux de Paris, 75010 Paris, France.

P Herman (P)

Department of Head & Neck Surgery, Lariboisière University Hospital, Assistance Publique-Hopitaux de Paris, 75010 Paris, France; Université de Paris, Diderot-Paris 7, 75010 Paris, France.

E Houdart (E)

Department of Neuroradiology, Lariboisière University Hospital, Assistance Publique-Hopitaux de Paris, 75010 Paris, France; Université de Paris, Diderot-Paris 7, 75010 Paris, France.

M-J Fraysse (MJ)

Department of Head & Neck Surgery, Toulouse University Hospital, 31300 Toulouse, France.

B Fraysse (B)

Department of Head & Neck Surgery, Toulouse University Hospital, 31300 Toulouse, France.

A Gillibert (A)

Department of Biostatistics, Rouen University Hospital, 76000 Rouen, France.

R Kania (R)

Department of Head & Neck Surgery, Lariboisière University Hospital, Assistance Publique-Hopitaux de Paris, 75010 Paris, France; Université de Paris, Diderot-Paris 7, 75010 Paris, France.

M Eliezer (M)

Department of Neuroradiology, Lariboisière University Hospital, Assistance Publique-Hopitaux de Paris, 75010 Paris, France; Université de Paris, Diderot-Paris 7, 75010 Paris, France. Electronic address: michael.eliezer@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH